Document and Entity Information - shares
|
3 Months Ended |
|
Mar. 31, 2022 |
Jul. 07, 2022 |
| Cover [Abstract] |
|
|
| Document Type |
10-Q
|
|
| Document Quarterly Report |
true
|
|
| Document Transition Report |
false
|
|
| Document Period End Date |
Mar. 31, 2022
|
|
| Entity File Number |
001-36672
|
|
| Entity Registrant Name |
KIORA PHARMACEUTICALS, INC.
|
|
| Entity Incorporation, State or Country Code |
DE
|
|
| Entity Tax Identification Number |
98-0443284
|
|
| Entity Address, Address Line One |
1371 East 2100 South
|
|
| Entity Address, Address Line Two |
Suite 200
|
|
| Entity Address, City or Town |
Salt Lake City
|
|
| Entity Address, State or Province |
UT
|
|
| Entity Address, Postal Zip Code |
84105
|
|
| City Area Code |
781
|
|
| Local Phone Number |
788-8869
|
|
| Title of 12(b) Security |
Common Stock, $0.01 par value
|
|
| Security Exchange Name |
NASDAQ
|
|
| Entity Current Reporting Status |
Yes
|
|
| Entity Interactive Data Current |
Yes
|
|
| Entity Filer Category |
Non-accelerated Filer
|
|
| Entity Small Business |
true
|
|
| Entity Emerging Growth Company |
false
|
|
| Entity Shell Company |
false
|
|
| Trading Symbol |
KPRX
|
|
| Entity Common Stock, Shares Outstanding |
|
13,067,426
|
| Entity Central Index Key |
0001372514
|
|
| Current Fiscal Year End Date |
--12-31
|
|
| Document Fiscal Year Focus |
2022
|
|
| Document Fiscal Period Focus |
Q1
|
|
| Amendment Flag |
false
|
|